1. Home
  2. AXTI vs APGE Comparison

AXTI vs APGE Comparison

Compare AXTI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$115.97

Market Cap

4.4B

Sector

Technology

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$82.77

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
APGE
Founded
1986
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.7B
IPO Year
1998
2023

Fundamental Metrics

Financial Performance
Metric
AXTI
APGE
Price
$115.97
$82.77
Analyst Decision
Hold
Strong Buy
Analyst Count
3
13
Target Price
$50.50
$109.67
AVG Volume (30 Days)
10.9M
520.1K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,361,000.00
N/A
Revenue This Year
$44.70
N/A
Revenue Next Year
$42.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.09
N/A
52 Week Low
$1.38
$34.34
52 Week High
$110.80
$95.32

Technical Indicators

Market Signals
Indicator
AXTI
APGE
Relative Strength Index (RSI) 73.21 49.11
Support Level $6.99 $73.06
Resistance Level N/A $84.56
Average True Range (ATR) 11.63 3.39
MACD 3.09 -0.93
Stochastic Oscillator 78.17 22.86

Price Performance

Historical Comparison
AXTI
APGE

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: